BRIEF-Gilead says European Commission grants marketing authorization for Odefsey
June 23, 2016 at 09:18 AM EDT
* European Commission grants marketing authorization for Gilead's single tablet regimen Odefsey (emtricitabine, rilpivirine, tenofovir alafenamide) for the treatment of HIV
